AU2003269478A1 - A novel process for amorphous rosuvastatin calcium - Google Patents

A novel process for amorphous rosuvastatin calcium

Info

Publication number
AU2003269478A1
AU2003269478A1 AU2003269478A AU2003269478A AU2003269478A1 AU 2003269478 A1 AU2003269478 A1 AU 2003269478A1 AU 2003269478 A AU2003269478 A AU 2003269478A AU 2003269478 A AU2003269478 A AU 2003269478A AU 2003269478 A1 AU2003269478 A1 AU 2003269478A1
Authority
AU
Australia
Prior art keywords
novel process
rosuvastatin calcium
amorphous rosuvastatin
amorphous
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269478A
Inventor
Dasari Muralidhara Reddy
Bandi Parthasaradhi Reddy
Rapolu Raji Reddy
Kura Rathnakar Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Drugs Ltd
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of AU2003269478A1 publication Critical patent/AU2003269478A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
AU2003269478A 2003-08-27 2003-08-27 A novel process for amorphous rosuvastatin calcium Abandoned AU2003269478A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000288 WO2005021511A1 (en) 2003-08-27 2003-08-27 A novel process for amorphous rosuvastatin calcium

Publications (1)

Publication Number Publication Date
AU2003269478A1 true AU2003269478A1 (en) 2005-03-16

Family

ID=34259913

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269478A Abandoned AU2003269478A1 (en) 2003-08-27 2003-08-27 A novel process for amorphous rosuvastatin calcium

Country Status (2)

Country Link
AU (1) AU2003269478A1 (en)
WO (1) WO2005021511A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2657076A1 (en) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin calcium
TW200526596A (en) 2003-11-24 2005-08-16 Teva Pharma Crystalline ammonium salts of rosuvastatin
DE602004032465D1 (en) 2003-12-02 2011-06-09 Teva Pharma REFERENCE STANDARD FOR THE CHARACTERIZATION OF ROSUVASTATIN
WO2005077917A1 (en) * 2004-01-19 2005-08-25 Ranbaxy Laboratories Limited Amorphous salts of rosuvastatin
ES2389565T3 (en) 2005-02-22 2012-10-29 Teva Pharmaceutical Industries Ltd. Rosuvastatin and salts thereof lacking rosuvatatin alkyl ether and a process for the preparation thereof
BRPI0605917A2 (en) 2005-08-16 2009-05-26 Teva Pharma rosuvastatin crystalline intermediate
HU227610B1 (en) * 2006-09-18 2011-09-28 Richter Gedeon Nyrt Pharmaceutical compositions containing rosuvastatin potassium
KR20080060284A (en) 2006-09-18 2008-07-01 테바 파마슈티컬 인더스트리즈 리미티드 Crystalline rosuvastatin calcium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (en) * 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives
GB0003305D0 (en) * 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
AU2003228010A1 (en) * 2002-05-21 2003-12-02 Ranbaxy Laboratories Limited Process for the preparation of rosuvastatin

Also Published As

Publication number Publication date
WO2005021511A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
AU2003299670A1 (en) Process for producing a liquid crystalline polymer
IL187578A0 (en) Process for preparing pure amorphous rosuvastatin calcium
AU2003901583A0 (en) A process
AU2003278406A1 (en) Amorphous form of esomeprazole salts
IL182474A0 (en) Process for forming amorphous atorvastatin
AU2003284161A1 (en) Method for making multifunctional materials
AU2003282384A1 (en) A novel process for ezetimibe intermediate
AU2003283870A1 (en) Process for preparing a composition
AU2003269478A1 (en) A novel process for amorphous rosuvastatin calcium
HUP0300761A3 (en) Process for the production of amorphous atorvastatin calcium
ZA200608632B (en) Process for forming amorphous atorvastatin calcium
AU2003230195A1 (en) A novel process for amorphous form of donepezil hydrochloride
AU2003227510A1 (en) Novel carbapenem compounds
AU2003223106A1 (en) A novel amorphous form of valsartan
AU2003275064A1 (en) Optimal crystallization parameter determination process
AU2002356423A1 (en) Process for the preparation of amorphous atorvastatin calcium
AU2003211227A1 (en) Process for producing azetidinone compounds
AU2003221374A1 (en) Process for producing paper
AU2003298519A1 (en) Methods for preparing a solid-fibrin web
AU2003251467A1 (en) Device for producing moulded bricks
AU2003223104A1 (en) A process for the preparation of indolymaleimides
AU2003902807A0 (en) A process for treating dust
AU2003245982A1 (en) Process for preparing styrene
AU2002953499A0 (en) Process for purifying inorganic materials
AU2003263743A1 (en) Process for making a thermoplastic vulcanizates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase